Physician profile
Lacey E Mcdaniel
NPI 1821895566
$1,473.09
in general payments reported to CMS, 2019-2025
20 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075 · Education: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,075.15 |
| Education | $397.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $235.91 | 2025 | Talvey, Darzalex, Tecvayli |
| Incyte Corporation | $178.00 | 2025 | Monjuvi, Jakafi |
| Daiichi Sankyo INC. | $132.05 | 2025 | Enhertu, Injectafer, Datroway |
| Merck Sharp & Dohme LLC | $112.11 | 2025 | Keytruda, Welireg, Keytruda Qlex |
| Glaxosmithkline, LLC. | $101.95 | 2025 | Jemperli |
| Seagen INC. | $99.99 | 2025 | |
| Gilead Sciences, INC. | $99.00 | 2025 | Trodelvy |
| Iovance Biotherapeutics, INC. | $86.17 | 2025 | Amtagvi |
| Lilly USA, LLC | $80.14 | 2025 | Verzenio, Jaypirca |
| Bayer Healthcare Pharmaceuticals INC. | $74.58 | 2025 | |
| Beone Medicines USA, INC. | $57.01 | 2025 | Brukinsa |
| Kyowa Kirin, INC. | $45.58 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $34.35 | 2025 | Imfinzi, Enhertu |
| Exelixis INC. | $28.87 | 2025 | Cabometyx |
| Genzyme Corporation | $26.94 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $18.61 | 2025 | Onivyde |
| Takeda Pharmaceuticals U.S.A., INC. | $18.55 | 2025 | Ninlaro |
| Sobi, INC | $14.98 | 2025 | |
| Aveo Pharmaceuticals, INC. | $14.68 | 2025 | |
| Pfizer INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.